| TCLCX | VIVIX | TCLCX / VIVIX | |
| Total Expense Ratio | 0.75 | 0.04 | 1,875% |
| Annual Report Gross Expense Ratio | 0.75 | 0.04 | 1,875% |
| Fund Existence | 23 years | 27 years | - |
| Gain YTD | 13.581 | 11.188 | 121% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.25B | 208B | 3% |
| Annual Yield % from dividends | 1.13 | 2.09 | 54% |
| Returns for 1 year | 7.62 | 7.68 | 99% |
| Returns for 3 years | 32.10 | 40.24 | 80% |
| Returns for 5 years | 54.33 | 74.15 | 73% |
| Returns for 10 years | 51.25 | 129.15 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| STCEX | 4.96 | 0.04 | +0.81% |
| Virtus Ceredex Small-Cap Value Eq C | |||
| TISVX | 18.15 | 0.05 | +0.28% |
| Transamerica International Sm Cp Val I | |||
| FACTX | 54.42 | 0.12 | +0.22% |
| Fidelity Advisor Health Care M | |||
| HWLAX | 46.80 | 0.08 | +0.17% |
| Hotchkis & Wiley Large Cap Fdml Value A | |||
| PCBIX | 46.25 | 0.03 | +0.06% |
| Principal MidCap Institutional | |||